Allergan Inc. (AGN) reported first quarter non-GAAP EPS of $0.98 Wednesday morning, compared to the consensus estimate of $0.96. The company expects to report second quarter non-GAAP EPS of $1.18 to $1.20 and between $4.70 and $4.76 for the full year 2013.
Allergan gapped open lower Wednesday and has since steadily declined on above average volume. The stock is now down 4.56 at $108.99 and has fallen to over a one-month low.
For comments and feedback: editorial@rttnews.com